| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 28, 2024 |
Principal Accounting Officer
Trans History: 64
|
Principal Accounting Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 34 | $24.50 | 3,579 |
| Oct 28, 2024 |
EVP & General Counsel
Trans History: 281
|
EVP & General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 152 | $24.50 | 15,721 |
| Oct 28, 2024 |
EVP & General Counsel
Trans History: 281
|
EVP & General Counsel | Form 4 | Other acquisition or disposition | -- | -- | 20,456 |
| Oct 28, 2024 |
Director
Trans History: 30
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
| Oct 25, 2024 |
Director
Trans History: 33
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 174 | -- | 28,246 |
| Oct 25, 2024 |
Director
Trans History: 153
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 218 | -- | 139,656 |
| Oct 25, 2024 |
EVP Chief Risk Officer
Trans History: 77
|
EVP Chief Risk Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 436 | -- | 48,714 |
| Oct 25, 2024 |
Director
Trans History: 240
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 235 | -- | 425,897 |
| Oct 25, 2024 |
Director
Trans History: 57
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 183 | -- | 138,033 |
| Oct 25, 2024 |
Director, President & CEO
Trans History: 705
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,432 | -- | 388,917 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.